Cancer Research Aziza Shad  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 9771, December 1, 2008. doi: 10.1158/0008-5472.CAN-08-1911
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hingorani, M.
Right arrow Articles by Harrington, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hingorani, M.
Right arrow Articles by Harrington, K. J.

Experimental Therapeutics, Molecular Targets, and Chemical Biology

Inhibition of Repair of Radiation-Induced DNA Damage Enhances Gene Expression from Replication-Defective Adenoviral Vectors

Mohan Hingorani1, Christine L. White1, Andrew Merron2, Inge Peerlinck2, Martin E. Gore3, Andrew Slade4, Simon D. Scott5, Christopher M. Nutting3, Hardev S. Pandha6, Alan A. Melcher7, Richard G. Vile8, Georges Vassaux2 and Kevin J. Harrington1,3

1 Targeted Therapy Team, The Institute of Cancer Research; 2 Centre for Molecular Oncology, Queen Mary's School of Medicine and Dentistry; 3 Head and Neck Unit, Royal Marsden Hospital, London, United Kingdom; 4 KuDOS Pharmaceuticals Ltd., Cambridge, United Kingdom; 5 Medway School of Pharmacy, University of Kent, Kent, United Kingdom; 6 University of Surrey, Guildford, United Kingdom; 7 St. James's University Hospital, Leeds, United Kingdom; and 8 Molecular Medicine Program, Mayo Clinic, Rochester, Minnesota

Requests for reprints: Kevin J. Harrington, Targeted Therapy Laboratory, The Institute of Cancer Research, Chester Beatty Laboratories, Cancer Research UK Centre for Cell and Molecular Biology, 237 Fulham Road, London SW3 6JB, United Kingdom. Phone: 20-7153-5157; Fax: 20-7808-2235; E-mail: kevinh{at}icr.ac.uk.

Key Words: adenovirus • DNA repair • double-strand breaks • gene expression • MAP kinase

Radiation has been shown to up-regulate gene expression from adenoviral vectors in previous studies. In the current study, we show that radiation-induced dsDNA breaks and subsequent signaling through the mitogen-activated protein kinase (MAPK) pathway are responsible, at least in part, for this enhancement of transgene expression both in vitro and in vivo. Inhibitors of ataxia-telangiectasia–mutated, poly(ADP-ribose) polymerase–mutated, and DNA-dependent protein kinase (DNA-PK)–mediated DNA repair were shown to maintain dsDNA breaks ({gamma}H2AX foci) by fluorescence-activated cell sorting and microscopy. Inhibition of DNA repair was associated with increased green fluorescent protein (GFP) expression from a replication-defective adenoviral vector (Ad-CMV-GFP). Radiation-induced up-regulation of gene expression was abrogated by inhibitors of MAPK (PD980059 and U0126) and phosphatidylinositol 3-kinase (LY294002) but not by p38 MAPK inhibition. A reporter plasmid assay in which GFP was under the transcriptional control of artificial Egr-1 or cytomegalovirus promoters showed that the DNA repair inhibitors increased GFP expression only in the context of the Egr-1 promoter. In vivo administration of a water-soluble DNA-PK inhibitor (KU0060648) was shown to maintain luciferase expression in HCT116 xenografts after intratumoral delivery of Ad-RSV-Luc. These data have important implications for therapeutic strategies involving multimodality use of radiation, targeted drugs, and adenoviral gene delivery and provide a framework for evaluating potential advantageous combinatorial effects. [Cancer Res 2008;68(23):9771–8]




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
I. Peerlinck, A. Merron, P. Baril, S. Conchon, P. Martin-Duque, C. Hindorf, J. Burnet, M. Quintanilla, M. Hingorani, R. Iggo, et al.
Targeted Radionuclide Therapy Using a Wnt-Targeted Replicating Adenovirus Encoding the Na/I Symporter
Clin. Cancer Res., November 1, 2009; 15(21): 6595 - 6601.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.